Joanna Robson

8.2k total citations · 7 hit papers
92 papers, 2.8k citations indexed

About

Joanna Robson is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Immunology. According to data from OpenAlex, Joanna Robson has authored 92 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Pulmonary and Respiratory Medicine, 59 papers in Rheumatology and 14 papers in Immunology. Recurrent topics in Joanna Robson's work include Vasculitis and related conditions (60 papers), Otitis Media and Relapsing Polychondritis (30 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (13 papers). Joanna Robson is often cited by papers focused on Vasculitis and related conditions (60 papers), Otitis Media and Relapsing Polychondritis (30 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (13 papers). Joanna Robson collaborates with scholars based in United Kingdom, United States and New Zealand. Joanna Robson's co-authors include Raashid Luqmani, Richard A. Watts, Ravi Suppiah, Peter A. Merkel, Anthea Craven, Peter C. Grayson, Cristina Ponte, Andrew Judge, Andrew Hutchings and Sara Khalid and has published in prestigious journals such as Annals of the Rheumatic Diseases, Archives of Disease in Childhood and Lara D. Veeken.

In The Last Decade

Joanna Robson

88 papers receiving 2.7k citations

Hit Papers

2022 American College of Rheumatology/European Alliance o... 2022 2026 2023 2024 2022 2022 2022 2022 2022 50 100 150 200

Peers

Joanna Robson
Joanna Robson
Citations per year, relative to Joanna Robson Joanna Robson (= 1×) peers Cristina Ponte

Countries citing papers authored by Joanna Robson

Since Specialization
Citations

This map shows the geographic impact of Joanna Robson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanna Robson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanna Robson more than expected).

Fields of papers citing papers by Joanna Robson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanna Robson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanna Robson. The network helps show where Joanna Robson may publish in the future.

Co-authorship network of co-authors of Joanna Robson

This figure shows the co-authorship network connecting the top 25 collaborators of Joanna Robson. A scholar is included among the top collaborators of Joanna Robson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanna Robson. Joanna Robson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moore, Elizabeth, Tracy Jackson, Ting Shi, et al.. (2025). Mapping Use of High Dose or Long‐Term Oral Glucocorticoids and Steroid‐Sparing Strategies in Adults With Chronic Conditions: A Rapid Scoping Review of Reviews. Pharmacoepidemiology and Drug Safety. 34(10). e70233–e70233. 1 indexed citations
2.
Dures, Emma, Celia Almeida, Sadia Janjua, et al.. (2025). Patients’ experiences of managing their rare rheumatic disease. Lara D. Veeken. 64(11). 5698–5706.
3.
Lax, S., Emma Dures, Vivien Lowndes, et al.. (2025). Patient perspectives on the impact of appearance and weight changes attributed to systemic glucocorticoid treatment of rheumatic diseases. Lara D. Veeken. 64(6). 3854–3862. 1 indexed citations
5.
Tieu, Joanna, Kevin Yip, Nilasha Ghosh, et al.. (2024). Prioritising domains of glucocorticoid therapy to measure in trials: Results from a modified delphi exercise from the OMERACT glucocorticoid impact working group. Seminars in Arthritis and Rheumatism. 71. 152602–152602. 1 indexed citations
6.
Ndosi, Mwidimi, Jill Dawson, Patricia Richards, et al.. (2023). OP0280-HPR VALIDATION OF A NEW GLUCOCORTICOID-SPECIFIC PATIENT REPORTED OUTCOME QUESTIONNAIRE (THE STEROID PRO). Annals of the Rheumatic Diseases. 82. 184–184. 1 indexed citations
7.
Yip, Kevin, Vasilis S. Vasiliou, David A. Katz, et al.. (2023). Consensus of the definitions of the OMERACT glucocorticoid impact core domain set for people with rheumatic and musculoskeletal diseases. Seminars in Arthritis and Rheumatism. 64. 152338–152338. 1 indexed citations
8.
Daniels, Jo, Miles Thompson, Joanna Robson, et al.. (2023). Health professionals' perspectives on psychological distress and meeting patients' support needs in rheumatology care settings: A qualitative study. Musculoskeletal Care. 21(2). 537–544.
9.
Robson, Joanna, Peter C. Grayson, Cristina Ponte, et al.. (2022). 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis. Annals of the Rheumatic Diseases. 81(3). 315–320. 212 indexed citations breakdown →
10.
Robson, Joanna, Peter C. Grayson, Cristina Ponte, et al.. (2021). 2020 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis. Annals of the Rheumatic Diseases. 1 indexed citations
11.
Sweeney, A, Candy McCabe, Caroline Flurey, et al.. (2020). The patient perspective of nurse‐led care in early rheumatoid arthritis: A systematic review of qualitative studies with thematic analysis. Journal of Clinical Nursing. 30(1-2). 145–160. 14 indexed citations
12.
Yates, Max, Claire Owen, Sara Müller, et al.. (2020). Feasibility and Face Validity of Outcome Measures for Use in Future Studies of Polymyalgia Rheumatica: An OMERACT Study. The Journal of Rheumatology. 47(9). 1379–1384. 7 indexed citations
13.
Dures, Emma, Sasha Shepperd, Sandeep Mukherjee, et al.. (2020). Treat-to-target in PsA: methods and necessity. RMD Open. 6(1). e001083–e001083. 20 indexed citations
14.
Dures, Emma, Julie Taylor, Sasha Shepperd, et al.. (2020). Mixed methods study of clinicians' perspectives on barriers to implementation of treat to target in psoriatic arthritis. Annals of the Rheumatic Diseases. 79(8). 1031–1036. 10 indexed citations
15.
Milman, Nataliya, Joanna Robson, Annelies Boonen, et al.. (2019). Updating OMERACT Core Set of Domains for ANCA-associated Vasculitis: Patient Perspective Using the International Classification of Function, Disability, and Health. The Journal of Rheumatology. 46(10). 1415–1420. 7 indexed citations
16.
Sreih, Antoine G., Fatma Alıbaz-Öner, Ebony Easley, et al.. (2018). Health-related outcomes of importance to patients with Takayasu's arteritis.. PubMed. 36 Suppl 111(2). 51–57. 13 indexed citations
17.
Sreih, Antoine G., Fatma Alıbaz-Öner, Tanaz A. Kermani, et al.. (2017). Development of a Core Set of Outcome Measures for Large-vessel Vasculitis: Report from OMERACT 2016. The Journal of Rheumatology. 44(12). 1933–1937. 33 indexed citations
18.
Robson, Joanna, Susan P. Ashdown, Jill Dawson, et al.. (2015). Patient Perceptions of Treatment with Glucocorticoids in ANCA-Associated Vasculitis. Arthritis & Rheumatism. 67. 1 indexed citations
19.
Robson, Joanna, A. Kiran, J. Maskell, et al.. (2013). PREDICTORS OF AORTIC ANEURYSMS FOR GIANT CELL ARTERITIS SUBJECTS. Lara D. Veeken. 52. 149–150. 1 indexed citations
20.
Jayne, David, Peter Höglund, Kerstin Westman, et al.. (2012). THE DISEASE CHARACTERISTICS OF ANCA ASSOCIATED VASCULITIS: 735 PATIENTS RECRUITED AT DIAGNOSIS TO SIX EUROPEAN VASCULITIS STUDY GROUP TRIALS. Nephrology. 17. 45–45. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026